Evidence map›Paper›PMID 25207820›Full record

ArticleThe Journal of investigative dermatology2015

Peripheral and local human papillomavirus 16-specific CD8+ T-cell expansions characterize erosive oral lichen planus.

Manuelle Viguier, Hervé Bachelez, Béatrice Poirier, Jérémy Kagan, Maxime Battistella, François Aubin, Antoine Touzé, Maryvonnick Carmagnat, Camille Francès, Marie-Lise Gougeon and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. HPV related p16BMC oral health · 2024
    Article
  4. Oral Lichen Planus: An Update on Diagnosis and Management.American journal of clinical dermatology · 2024
    Review
  5. CD8eLife · 2023
    Article
  6. Review
  7. Lichen Planus.Frontiers in medicine · 2021
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Manuelle ViguierAntiviral Immunity Biotherapy and Vaccine Unit, Institut Pasteur, Paris, France; Sorbonne Paris Cité Université Paris Diderot, Paris, France.
Hervé BachelezSorbonne Paris Cité Université Paris Diderot, Paris, France; Université Paris Descartes, Imagine Institute, Necker Hospital, Paris, France. Electronic address: herve.bachelez@sls.aphp.fr.
Béatrice PoirierAntiviral Immunity Biotherapy and Vaccine Unit, Institut Pasteur, Paris, France.
Jérémy KaganCentre de Physiopathologie de Toulouse Purpan, Toulouse, France; INSERM, U1043, Toulouse, France; CNRS, UMR5282, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France.
Maxime BattistellaAntiviral Immunity Biotherapy and Vaccine Unit, Institut Pasteur, Paris, France; Université Paris Diderot, UMR-S728, INSERM, Paris, France.
François AubinService de Dermatologie, Centre Hospitalier Universitaire, SFR FED 4234, EA 3181, Université de Franche Comté, Besançon, France.
Antoine TouzéUMR 1282 INRA-Université François Rabelais, Tours, France.
Maryvonnick CarmagnatLaboratoire d'Immunologie, Hôpital Saint-Louis, Paris, France.
Camille FrancèsService de Dermatologie-Allergologie, Hôpital Tenon, Université Paris VI, AP-HP, Paris, France.
Marie-Lise GougeonAntiviral Immunity Biotherapy and Vaccine Unit, Institut Pasteur, Paris, France. Electronic address: mlgougeo@pasteur.fr.
Nicolas FazilleauCentre de Physiopathologie de Toulouse Purpan, Toulouse, France; INSERM, U1043, Toulouse, France; CNRS, UMR5282, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France. Electronic address: nicolas.fazilleau@inserm.fr.
Institut Pasteur · FRCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FRHôpital Saint-Louis · FRInserm · FRSorbonne Université · FRUniversité de franche-comté · FRUniversité de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erosive oral lichen planus (OLP) is a chronic, disabling mucocutaneous dysimmune rare disease characterized by mucosal inflammatory erosive lesions with pathological evidence for a marked CD8+ cytotoxic T-lymphocyte (CTL) infiltration. However, the specificity of lesional CTL in OLP has never been analyzed. To investigate the molecular mechanisms underlying dysregulation of T-cell immune responses in patients with OLP, we studied the diversity and antigen specificity of the TCR expressed by CD8+ T cells using dextramer staining, spectratyping, and TCR sequencing in 10 OLP patients undergoing extracorporeal photochemotherapy. Expansions of TCRVβ3-bearing CD8+ T cells were found in peripheral blood and in lesional tissues of OLP patients. Spectratyping and sequencing studies identified specific clonotypes in each patient. These expansions were enriched with human papillomavirus 16 (HPV16)-specific CD8+ T cells in HLA-A*0201+ patients as shown by their immune recognition of the E711-20 immunodominant epitope. Under treatment with extracorporeal photochemotherapy, clonotypic CD8+ T-cell expansions decreased in parallel with clinical remission. Altogether, these data establish a link between HPV infection and OLP pathogenesis by identifying a massive clonal expansion of CD8+ T cells with increased frequency of HPV 16-specific CD8+ T cells in OLP patients.

Indexed as

AdultAgedCD8-Positive T-LymphocytesFemaleGenes, T-Cell Receptor betaHuman papillomavirus 16HumansLichen Planus, OralMaleMiddle Aged

Identifiers

PMID25207820
OpenAlexW1984725422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.